ASLAN PHARMACEUTICALS LIMITED Inactive Instrument
Calendar ASLAN Pharmaceuticals Limited Taipei Exchange
Equities
6497
KYG054241099
Chart calendar ASLAN Pharmaceuticals Limited
12242eab8ae602e44b6.0rVH7HlmLfcMT9RHNJq9Ziy3x21sTPaB0a9iz79YV-8.pYwEhkkHHppAJq4iWtn_DkvFsx4gJJjwnPsk--xtM5mc5xK2PQpOhz99gQ~e027e0d6729fc6d196649afe5de11831
Upcoming events on ASLAN Pharmaceuticals Limited
Past events on ASLAN Pharmaceuticals Limited
| 09/05/2024 12:00 | Q1 2024 Earnings Release |
| 07/05/2024 13:00 | Investor Meeting - Key Opinion Leader |
| 12/04/2024 13:00 | Q4 2023 Earnings Release |
| 28/03/2024 12:00 | H.C. Wainwright Autoimmune and Inflammatory Disease Conference |
| 09/01/2024 | LifeSci Partners Corporate Access Event |
| 07/01/2024 | Biotech Showcase |
| 06/01/2024 | Dermatology Summit |
| 29/11/2023 16:30 | Piper Sandler Healthcare Conference |
| 30/10/2023 | Dermatology Drug Development Summit |
| 27/10/2023 13:00 | Q3 2023 Earnings Release |
| 24/10/2023 16:00 | Investor Meeting - Key Opinion Leader |
| 11/09/2023 15:30 | H.C. Wainwright Global Investment Conference |
| 11/08/2023 12:00 | Q2 2023 Earnings Release |
| 06/07/2023 13:30 | TREK-AD Phase 2b Trial Results Call |
| 08/06/2023 21:30 | Jefferies Global Healthcare Conference |
| 13/05/2023 05:15 | International Societies for Investigative Dermatology Meeting - Abstract Number : LB1751 |
| 09/05/2023 | International Societies for Investigative Dermatology Meeting - Abstract Number : LB1777 |
| 09/05/2023 | International Societies for Investigative Dermatology Meeting - Abstract Number : 657 |
| 09/05/2023 | International Societies for Investigative Dermatology Meeting - Abstract Number : 1594 |
| 28/04/2023 12:00 | Q1 2023 Earnings Release |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million TWD | Released Forecast Spread | 90,7 91,4 -0.81% | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 387 379 2.21% | 0,00 |
|
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million TWD | Released Forecast Spread | -1 378 -674 -104.55% | -463 -402 -15.28% | -971 -889 -9.19% | -1 451 -1 404 -3.35% | -1 411 -1 321 -6.77% | -1 640 |
|
Earnings before Tax (EBT) Million TWD | Released Forecast Spread | -1 410 -682 -106.67% | -477 -427 -11.78% | -906 -850 -6.61% | -1 554 -1 506 -3.23% | -1 422 -1 347 -5.55% | -1 718 |
|
Net income Million TWD | Released Forecast Spread | -1 421 -694 -104.65% | -455 -423 -7.7% | -898 -857 -4.76% | -1 557 -1 506 -3.39% | -1 427 -1 350 -5.64% | -1 718 |
|
EPS USD | Released Forecast Spread | -7,25 -3,70 -95.95% | -2,00 -1,43 -39.54% | -2,40 -2,38 -0.7% | -3,68 -2,12 -74% | -2,69 -2,61 -3.07% | -3,34 |
| Announcement Date | 18/03/20 | 22/04/21 | 25/03/22 | 24/03/23 | 12/04/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million TWD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 381 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 |
|
EBIT Million TWD | Released Forecast Spread | -319 -258 -23.66% | -349 -291 -19.94% | -369 -372 0.85% | -330 -394 16.46% | -406 -349 -16.18% | -557 -398 -39.89% | -75,2 -479 84.29% | -338 -460 26.43% | -414 -346 -19.63% | -301 -371 18.73% | -410 | -410 | -410 |
|
Earnings before Tax (EBT) Million TWD | Released Forecast Spread | -262 -268 2.24% | -380 -310 -22.47% | -391 -403 3.07% | -349 -425 17.76% | -436 -378 -15.33% | -588 -423 -39.15% | -58,1 -527 88.97% | -314 -494 36.35% | -435 -381 -14.03% | -322 -397 19.06% | -429 | -429 | -429 |
|
Net income Million TWD | Released Forecast Spread | -262 -277 5.41% | -380 -310 -22.47% | -391 -419 6.77% | -350 -425 17.69% | -439 -378 -15.97% | -588 -423 -39.2% | -59,9 -496 87.91% | -315 -494 36.16% | -436 -381 -14.37% | -322 -397 19.06% | -429 | -429 | -429 |
|
EPS USD | Released Forecast Spread | -0,80 -0,72 -11.63% | -0,95 -0,90 -5.56% | -0,95 -0,60 -58.33% | -0,80 -0,95 15.79% | -1,04 -0,55 -90.83% | -1,29 -0,44 -196.55% | -0,11 -0,80 86.25% | -0,56 -0,77 27.27% | -0,79 -0,65 -21.54% | -0,53 -0,61 13.11% | |||
| Announcement Date | 25/03/22 | 27/04/22 | 12/08/22 | 28/10/22 | 24/03/23 | 28/04/23 | 11/08/23 | 27/10/23 | 12/04/24 | 09/05/24 | - | - | - |
More events
Past sector events for ASLAN Pharmaceuticals Limited
| 10/05/2024 21:02 | CASSAVA SCIENCES, INC.: Q1 2024 Earnings Release |
| 10/05/2024 13:26 | ITEOS THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 10/05/2024 13:00 | PRIME MEDICINE, INC.: Q1 2024 Earnings Release |
| 10/05/2024 12:00 | AKERO THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 10/05/2024 01:05 | SOLENO THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 09/05/2024 | TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release (Projected) |
| 09/05/2024 21:15 | ANAPTYSBIO, INC.: Q1 2024 Earnings Release |
| 09/05/2024 21:10 | ASTRIA THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 09/05/2024 21:09 | XENCOR, INC.: Q1 2024 Earnings Release |
| 09/05/2024 21:05 | STRUCTURE THERAPEUTICS INC.: Q1 2024 Earnings Release |
